Neurocrine Biosciences (NBIX) Earnings Date & Reports

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NBIX is expected to report earnings to fall 19.07% to $1.57 per share on August 04

Neurocrine Biosciences NBIX Stock Earnings Reports

Q2'26

Est.

$1.57

Q1'26

Beat

by $0.77

Q4'25

Beat

by $0.02

Q3'25

Beat

by $0.58

Q2'25

Beat

by $0.69

The last earnings report on May 05 showed earnings per share of $1.94, beating the estimate of $1.17. With 1.05M shares outstanding, the current market capitalization sits at 16.48B.

View a ticker or compare two or three

Compare

NBIX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for NBIX